Tag: GoI

The Union health ministry is planning to develop a technical guide to monitor the adverse effects (AEs) and adverse drug reactions (ADRs)...

Center has released new guidelines for treating Mucormycosis or black fungus disease in children below the age of 18 years.

Govt issues guidelines for Rational use of medicines, tests for C-19 NEW DELHI: The Union Health Ministry on Monday dropped...

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has capped the trade margin for oxygen concentrators at 70 per cent, the Ministry of Chemicals and Fertilizers...

The government issued operational guidelines for the production linked incentive (PLI) scheme for the pharmaceutical industry. The Department of...

The Department of Pharmaceuticals (DoP) has issued revised guidelines under the production linked incentive (PLI) scheme for promoting domestic manufacturing of medical...

The Union government has decided to provide on-site registration / facilitated cohort registration facility on CoWIN digital platform for 18-44 years age...

Reiterating the importance of full protection through two C-19 vaccine doses, Union Minister of Health and Family Welfare Dr Harsh Vardhan today...

Various steps have been taken by Government of India to address the emerging issues for effective management of the recent unprecendented spike...

The issue of availability of Remdesivir was reviewed by Shri Mansukh Mandaviya, Minister of State, For Ports, Shipping and Waterways (Independent Charge)...

New Delhi: Industry body FICCI on Tuesday recommended the government to provide Production Linked Incentive-type scheme in order to ramp up C-19 vaccine production...

As C-19 cases surge in the country , the government of India on Sunday ordered prohibition on the export of Remdesivir drug...

The government said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity...

The Union health ministry has notified two government analysts in respect of all classes of drugs at Regional Drugs Testing Laboratory, Chandigarh.

The Department of Pharmaceuticals (DoP) has incorporated 19 medical devices in the revised guidelines of the public procurement policy. The revised order...

Regional Centre for Biotechnology (RCB), an Institution of national importance established by the Department of Biotechnology, Govt. of India, with regional and...

The Centre is likely to announce guidelines for the ₹15,000 crore production-linked incentive (PLI) scheme for the pharma sector in March, pharma secretary...

Glenmark Pharmaceuticals received the “India Pharma Innovation of the Year” Award, as part of the India Pharma & India Medical Device Awards...

Pharma Industry welcomes PLI Scheme, awaits implementation details The Union Cabinet’s decision to approve the Production Linked Incentive (PLI) 2.0...

PLI Scheme for Pharmaceuticals approved: Read the details The Union Cabinet, chaired by Prime Minister Narendra Modi on Wednesday approved the Production Linked...

All India Drugs Control Officers’ Confederation (AIDCOC) has made a representation to Govt of India requesting to include Drugs Control Officers as Frontline Workers and...

Amendments introduced by Drugs and Cosmetics (Amendment) Rules, 2020 by notification No. GSR 101(E) dated 11.02.2020. To read...

CHANDIGARH: To give more impetus to medical industry in state, Punjab Government will set up three pharma park and medical device parks...

The Union health ministry has issued draft notification vide No. GSR 98 (E) dt 05-02-2021 on Medical Devices Amendment Rules, 2021 to...